D.E. Shaw & Co
GLSI icon

D.E. Shaw & Co’s Greenwich LifeSciences GLSI Stock Holding History

D.E. Shaw & Co’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,631
Closed -$149K – 5306
2022
Q2 		$149K Buy
+17,631
New +$202K ﹤0.01% 4644
2022
Q1 		– Sell
-10,450
Closed -$254K – 5675
2021
Q4 		$254K Buy
+10,450
New +$350K ﹤0.01% 4764

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D.E. Shaw & Co's GLSI Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Greenwich LifeSciences (GLSI) in Q3 2022, closing a stake of 17,631 shares — an estimated $149K sold.

D.E. Shaw & Co first reported a position in GLSI in Q4 2021 and held it in 2 quarters. The position peaked at $254K in Q4 2021. 21 funds tracked by Wall St. Rank hold GLSI as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Greenwich LifeSciences position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 17,631 Greenwich LifeSciences shares in Q3 2022, an estimated $149K.
  • D.E. Shaw & Co first reported a position in Greenwich LifeSciences in Q4 2021 and held it in 2 quarters.
  • D.E. Shaw & Co's Greenwich LifeSciences position peaked at $254K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.